Keyphrases
Peru
100%
Cusco
53%
Peruvian
53%
Hospitalized Patients
48%
Antimicrobial Resistance
38%
COVID-19
31%
High Altitude
20%
Bloodstream Infection
19%
Antibiotics
19%
Risk Factors
18%
Gram-negative Bacteria
18%
Escherichia Coli
15%
Uropathogenic E. Coli
15%
Extended-spectrum-lactamase
15%
Uropathogenic Escherichia Coli
15%
ESBL-producing
15%
Resistance Dynamics
15%
Seroprevalence
15%
Antimicrobial Susceptibility Pattern
15%
Flavus
15%
Point Prevalence Survey
15%
Rabies
15%
Non-HIV Cryptococcal Meningitis
15%
Methicillin-resistant Staphylococcus Aureus
15%
Multicenter Cohort Study
15%
Animal Health
15%
Lambda
15%
Variants of Concern
15%
Severe Acute Respiratory Syndrome Coronavirus 2 Variants
15%
Potential Threats
15%
Public Health
15%
Natural Selection
15%
Staphylococcus Aureus Bloodstream Infection
15%
COVID-19 Mortality
15%
Surgical Removal
15%
Clinical Tropical Medicine
15%
Cryptococcosis
15%
Hydatidosis
15%
Medical Treatment
15%
Cyst
15%
Abdominal
15%
Young Males
15%
Albendazole
15%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
15%
Klebsiella Pneumoniae (K. pneumoniae)
13%
Carbapenems
12%
Resistance Pattern
11%
Carbapenem Resistance
10%
Rural Areas
10%
Fungal Burden
9%
Medicine and Dentistry
Antibiotic Resistance
30%
Infection
18%
Bloodstream Infection
15%
Gram-Negative Bacteria
15%
Prevalence
15%
Cohort Analysis
15%
COVID-19
15%
Natural Selection
15%
Penicillinase
15%
Uropathogenic Escherichia Coli
15%
Extended Spectrum Beta Lactamase
15%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Cryptococcosis
15%
Human T-Lymphotropic Virus 1
15%
Tropical Disease
15%
Intensive Care Unit
7%
Assisted Ventilation
7%
Urinary Tract Infection
6%
Pseudomonas aeruginosa
5%
Escherichia coli
5%
Bacterium Isolate
5%
Retroviridae
5%
Immune Deficiency
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotic Resistance
46%
Antimicrobial Resistance
30%
Prevalence
30%
Bloodstream Infection
30%
Gram Negative Bacterium
19%
Carbapenem Derivative
17%
HIV
15%
Methicillin-Resistant Staphylococcus Aureus
15%
Antibiotics
15%
Cryptococcal Meningitis
15%
Escherichia coli
13%
Staphylococcus Aureus
8%
Cephalosporin Derivative
7%
Combination Therapy
6%
Antiinfective Agent
5%
Pseudomonas aeruginosa
5%
Klebsiella pneumoniae
5%
Third Generation Cephalosporin
5%
